Utilizza questo identificativo per citare o creare un link a questo documento:
|Titolo:||Endocrinopathies, metabolic disorders and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.|
|Autori interni:||CHIRICO, VALERIA|
SALPIETRO DAMIANO, Carmelo
|Data di pubblicazione:||2014|
|Rivista:||EUROPEAN JOURNAL OF HAEMATOLOGY|
|Abstract:||Introduction Endocrinopathies and metabolic disorders characterized β thalassemic (βT) patients and the prevention and treatment of these comorbidities are important targets to be achieved. The aim of the study was to analyse the diagnostic and prognostic role of ferritin for endocrinopathies and metabolic disorders in βT patients. Ability of iron chelators to treat iron overload and to prevent or reverse metabolic disorders and endocrinopathies was also evaluated. Patients and Methods 72 βT patients were treated with different chelation strategies during the study. Receiver operating characteristics analysis was employed to calculate the area under the curve for serum ferritin to find the best cut off values capable of identifying endocrine dysfunction in thalassemic patients. Kaplan-Meier curves were generated to assess incidence of endocrinopathy. Adjusted risk estimates for endocrinopathy were calculated using univariate followed by multivariate Cox proportional hazard regression analysis. Results High ferritin levels were observed in patients with hypothyroidism [1500(872.5-2336.5)μg/L], hypogonadism [878(334-2010)μg/L] and in patients with hypoparathyroidism or osteoporosis, [834(367- 1857)μg/L]. A strict correlation between ferritin and T2* magnetic resonance imaging of heart (r=- 0.64;p:0.0006) and liver (r=-0.40;p:0.03) values was observed. Patients with ferritin values above 1800 μg/L experienced a significantly faster evolution to hypothyroidism [log-rank (χ2 ):7.7;p=0.005], hypogonadism [log-rank (χ2 ):10.7;p=0.001] and multiple endocrinopathies [log-rank(χ2 ):5.72;p=0.02]. Ferritin predicted high risk of endocrine dysfunction independently of confounding factors (HR:1.23;p<0.0001). The intensification of chelation therapy led to an amelioration of hypothyroidism.|
|Appare nelle tipologie:||14.a.1 Articolo su rivista|
File in questo prodotto:
Non ci sono file associati a questo prodotto.
- PubMed Central loading...
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.